Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Privia Health Group, Inc. - Common Stock (NQ: PRVA )

23.48 +0.09 (+0.38%)
Streaming Delayed Price Updated: 2:03 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Investigating Privia Health Gr's Standing In Health Care Providers &amp; Services Industry Compared To Competitors
Via Benzinga
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
Assessing Privia Health Gr: Insights From 10 Financial Analysts
Via Benzinga
1 of Wall Street’s Favorite Stock to Research Further and 2 to Steer Clear Of
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Earnings Scheduled For February 27, 2025
Via Benzinga
What Analysts Are Saying About Privia Health Gr Stock
Via Benzinga
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts
Via Benzinga
Key Takeaways From Privia Health Gr Analyst Ratings
Via Benzinga
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care. 
Via Benzinga
How Is The Market Feeling About Privia Health Gr?
Via Benzinga
2 Reasons to Sell PRVA and 1 Stock to Buy Instead
Even during a down period for the markets, Privia Health has gone against the grain, climbing to $22.91. Its shares have yielded a 29.3% return over the last six months, beating the S&P 500 by 30.9%.... 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Forecasting The Future: 7 Analyst Projections For Privia Health Gr
Via Benzinga
What 12 Analyst Ratings Have To Say About Privia Health Gr
Via Benzinga
Breaking Down Privia Health Gr: 10 Analysts Share Their Views
Via Benzinga
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for. 
Via StockStory
3 Stocks Under $50 Walking a Fine Line
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q4 CY2024, with sales up 4.6% year on year to $460.9 million. On the other hand, the company’s... 
Via StockStory
Where Privia Health Gr Stands With Analysts
Via Benzinga
Analyst Scoreboard: 8 Ratings For Privia Health Gr
Via Benzinga
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
Insiders Buying Hilton Worldwide And 2 Other Stocks
Via Benzinga
PRVA Stock Earnings: Privia Health Gr Beats EPS, Misses Revenue for Q1 2024
PRVA stock results show that Privia Health Gr beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Privia Health Gr
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Privia Health Gr's Earnings: A Preview
Via Benzinga
B of A Securities Downgrades Privia Health Gr: Here's What You Need To Know
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.